mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0004 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0005 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0005 |